Application of encapsulated cell technology for retinal degenerative diseases. - Wikidata - awgldk - TriplyDB

Application of encapsulated cell technology for retinal degenerative diseases.

Application of encapsulated cell technology for retinal degenerative diseases.

http://www.wikidata.org/entity/Q36521847

about

Emerging gene therapies for retinal degenerations Therapeutic potential of optogenetic neuromodulation CNTF induces regeneration of cone outer segments in a rat model of retinal degeneration Long-term efficacy of ciliary muscle gene transfer of three sFlt-1 variants in a rat model of laser-induced choroidal neovascularization CNTF and retina Effect of CNTF on retinal ganglion cell survival in experimental glaucoma Functional cone rescue by RdCVF protein in a dominant model of retinitis pigmentosa.Retinitis pigmentosa and allied conditions today: a paradigm of translational research Ocular delivery of macromolecules Construction of a eukaryotic expression plasmid for human retina-derived neurotrophin-3.CNGB3-achromatopsia clinical trial with CNTF: diminished rod pathway responses with no evidence of improvement in cone function Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration.Fibrosis and diseases of the eye.Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin New therapeutic targets in atrophic age-related macular degeneration.Safety evaluation of ocular drug delivery formulations: techniques and practical considerations.Phenotypic variation and genotype-phenotype discordance in canine cone-rod dystrophy with an RPGRIP1 mutation.Redefining tissue engineering for nanomedicine in ophthalmology.Emerging therapeutic approaches in the management of retinal angiogenesis and edema.Clinical and Rehabilitative Management of Retinitis Pigmentosa: Up-to-Date.Advances in ocular drug delivery: emphasis on the posterior segment.Neurotrophin family members as neuroprotectants in retinal degenerations.Stem cells in clinical trials for treatment of retinal degeneration.Recent developments in ocular drug delivery.Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications.Drug delivery to the eye: what benefits do nanocarriers offer?Retinal expression of Fgf2 in RCS rats with subretinal microphotodiode array.Combination therapies in ophthalmology: implications for intravitreal delivery.When is macular edema not macular edema? An update on macular telangiectasia type 2.An ADAM9 mutation in canine cone-rod dystrophy 3 establishes homology with human cone-rod dystrophy 9 Switching on the lights: the use of optogenetics to advance retinal gene therapy.Regeneration of cone outer segments induced by CNTF.Ciliary neurotrophic factor (CNTF) delivery to retina: an overview of current research advancements.How are we improving the delivery to back of the eye? Advances and challenges of novel therapeutic approaches.Protective effects of the neuropeptide PACAP in diabetic retinopathy.

P2860

Q26853366-768A1385-5DE2-4F37-9EC0-1C5DFE408839 Q28084334-26495B17-33BA-4108-87EF-AD95E4CA374C Q28572876-58A4A2A6-873C-4416-A6A6-A8638148C031 Q28582445-63ECA6DB-2C07-499F-B144-70BEE7EF38B8 Q28731691-B89CB56F-CC9A-4094-8C2E-75A464D26A07 Q33390314-BB769B8F-D308-49D9-8EC3-F70ED0F90C10 Q33713504-C67FB660-D50B-402A-9873-F9A98C2FB702 Q33918834-70223653-C575-42D7-B4AA-7CEE6EE4178F Q34079676-B732B5F0-BA0A-46FF-9A8C-9A327A9CC83A Q34094461-6B053ECA-93D1-4186-A0F9-045482644921 Q34312144-95C3CEDA-427D-436F-ABD2-8EC14B6436CD Q34794630-CD42F9A3-7E23-4568-AB1A-7A0BDE670253 Q35649477-988501D0-32AA-4E9E-9BBF-ACEC5CA37EC6 Q36319298-106FCB9F-A97B-4B84-AABE-E7715E0118D8 Q36804427-5DF04376-F3BC-4ABF-B949-1578EA48A28F Q37109083-69A745D9-CD92-4A99-A479-02158E996310 Q37425238-B4F599E3-ADA9-49DA-9927-2276737761B6 Q37782373-E568B704-DD41-474E-8ACE-5C8FB8EC01A7 Q37822290-17C56901-2180-4EE5-A980-A5253CCD5EAF Q37963356-6792AA83-6AAD-4046-BF8D-616561AB0009 Q38224320-70C4A158-6198-4082-AFD5-68004D4E1A24 Q38269424-92E5663E-3C13-4D7C-AD3B-6D1C22B48B63 Q38594426-3CF41FD5-E81C-4481-BF52-A8EFA64A5577 Q38603354-44663863-B15E-4A43-ACD5-E2349C574A43 Q38934604-05049532-9FDB-4869-B562-563341C1FB8B Q39130097-9FB28345-DBCB-4748-9B48-4D721B36049D Q39352997-727D2304-6011-4E3A-B9BC-DC3271463862 Q42008678-4E8DD4AF-5B51-4F4C-8976-979033BD3CE7 Q42359936-400A6546-6C72-466E-8783-0A0D674F94B5 Q42522157-18F0D90F-0C6F-42B6-B2AF-D4A359170FC1 Q42786548-0210C4DA-7FB3-452B-91C5-CE2EF0CCBDB7 Q42935416-B9882F42-A973-4489-AAC5-75DBDC29C12A Q47601916-0DC8B18A-E0B7-4DB5-ADF0-1DE4D9C8D747 Q48902538-88E5A91B-7B9B-494C-9312-ED772B621DBE Q54323129-7F7E7760-FACB-4D40-9E04-96F0A16CED45

P2860

Application of encapsulated cell technology for retinal degenerative diseases.

http://www.wikidata.org/entity/Q36521847

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Application of encapsulated cell technology for retinal degenerative diseases.

@ast

Application of encapsulated cell technology for retinal degenerative diseases.

@en

type

label

Application of encapsulated cell technology for retinal degenerative diseases.

@ast

Application of encapsulated cell technology for retinal degenerative diseases.

@en

prefLabel

Application of encapsulated cell technology for retinal degenerative diseases.

@ast

Application of encapsulated cell technology for retinal degenerative diseases.

@en

P1433

Q36521847-1EA7597A-13BF-4F97-9B5F-2F5AF9ECC6CD

P1476

Q36521847-5654E8EB-3F81-474C-9132-8B0495E027B3

P2093

Q36521847-7FB3752A-22C7-4316-A4E1-8457A29A2956

P2860

Q36521847-062C72FF-CB9C-4971-AEE9-A335A1521F9D

Q36521847-08C1E5FA-80D9-4C90-9150-C411538CE3BA

Q36521847-0F5DB29C-8991-4BF6-8417-B41F2297E4C8

Q36521847-1529573B-926A-403C-94C1-2386B1B40F46

Q36521847-182A899A-3038-4538-B4FD-C598509D619F

Q36521847-21544035-9C91-4F0D-B8A1-B16D7C00A30E

Q36521847-2FA9D6F5-15FA-4ACC-8065-97150A98F893

Q36521847-37691862-0BC7-49DF-B114-9EB72AC62DF6

Q36521847-44154C87-DC52-438C-B6E6-5AAED4F907C1

Q36521847-54C18A12-8EB7-43D5-85CC-19CEBD96ECBD

P304

Q36521847-57123950-1106-4E07-946E-8B461082DACC

P31

Q36521847-8EED11B5-68CB-4EE1-AA0C-5D82B4134A7F

P356

Q36521847-FA70E91D-4B63-4D47-BB0D-9437BB319FA9

P407

Q36521847-A052B837-37FF-4C8E-B326-413EE8A7F17C

P433

Q36521847-8B71C04F-3D57-4F8C-A1A1-30E745356E6A

P478

Q36521847-B7FA28F2-C9C0-4CF5-BF8E-8059D1DFA1C2

P577

Q36521847-7B09121C-561E-4486-A50D-E2E6AE48219F

P5875

Q36521847-366421CA-EB52-4B8A-AB53-43B3A7FE59EE

P698

Q36521847-3BDEBFE0-84BF-41AC-BC99-43DBC91443BA

P356

14712598.6.7.717

P1433

Expert Opinion on Biological Therapy

P1476

Application of encapsulated cell technology for retinal degenerative diseases.

@en

P2093

Weng Tao

http://www.w3.org/2001/XMLSchema#string

P2860

A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3)

CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: the possible involvement of STAT3 pathway

Pharmacological therapy for glaucoma: a review.

Looking forward to 20/20: a focus on the epidemiology of eye diseases.

Survival and axonal regeneration of retinal ganglion cells in adult cats.

Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants

The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor.

Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light.

Age-specific causes of bilateral visual impairment.

Sustained secretion of ciliary neurotrophic factor to the vitreous, using the encapsulated cell therapy-based NT-501 intraocular device.

P304

717-726

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.6.7.717

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6978402

http://www.w3.org/2001/XMLSchema#string

P698

16805711

http://www.w3.org/2001/XMLSchema#string